Literature DB >> 23499527

Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.

C R Parish1, C Freeman, A F Ziolkowski, Y Q He, E L Sutcliffe, A Zafar, S Rao, C J Simeonovic.   

Abstract

Heparanase (Hpse) is an endo-β-d-glucuronidase that degrades the glycosaminoglycan heparan sulfate (HS) in basement membranes (BMs) to facilitate leukocyte migration into tissues. Heparanase activity also releases HS-bound growth factors from the extracellular matrix (ECM), a function that aids wound healing and angiogenesis. In disease states, the degradation of HS in BMs by heparanase is well recognized as an invasive property of metastatic cancer cells. Recent studies by our group, however, have identified unexpected new roles for heparanase and HS. First, we discovered that in Type 1 diabetes (T1D) (i) HS in the pancreatic islet BM acts as a barrier to invading cells and (ii) high levels of HS within the insulin-producing islet beta cells themselves are critical for beta cell survival, protecting the cells from free radical-mediated damage. Furthermore, catalytically active heparanase produced by autoreactive T cells and other insulitis mononuclear cells was shown to degrade intra-islet HS, increasing the susceptibility of islet beta cells to free radical damage and death. This totally novel molecular explanation for the onset of T1D diabetes opens up new therapeutic approaches for preventing disease progression. Indeed, administration of the heparanase inhibitor, PI-88, dramatically reduced T1D incidence in diabetes-prone NOD mice, preserved islet beta cell HS and reduced islet inflammation. Second, in parallel studies it has been shown that heparanase and HS can be transported to the nucleus of cells where they impact directly or indirectly on gene transcription. Based on ChIP-on-chip studies heparanase was found to interact with the promoters and transcribed regions of several hundred genes and micro-RNAs in activated Jurkat T cells and up-regulate transcription, with many of the target genes/micro-RNAs being involved in T cell differentiation. At the molecular level, nuclear heparanase appears to regulate histone 3 lysine 4 (H3K4) methylation by influencing the recruitment of demethylases to transcriptionally active genes. These studies have unveiled new functions for heparanase produced by T lymphocytes, with the enzyme mediating unexpected intracellular effects on T cell differentiation and insulin-producing beta cell survival in T cell-dependent autoimmune T1D. Crown
Copyright © 2013. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23499527     DOI: 10.1016/j.matbio.2013.02.007

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  34 in total

Review 1.  Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.

Authors:  Hans-Joachim Anders; Liliana Schaefer
Journal:  J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 10.121

2.  Involvement of Heparanase in Empyema: Implication for Novel Therapeutic Approaches.

Authors:  Moshe Lapidot; Uri Barash; Yaniv Zohar; Yuval Geffen; Inna Naroditsky; Neta Ilan; Lael Anson Best; Israel Vlodavsky
Journal:  J Clin Cell Immunol       Date:  2015-02

Review 3.  The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy.

Authors:  Stephen Douglass; Atul Goyal; Renato V Iozzo
Journal:  Connect Tissue Res       Date:  2015-07-16       Impact factor: 3.417

4.  The potential of heparanase as a therapeutic target in cancer.

Authors:  Claudio Pisano; Israel Vlodavsky; Neta Ilan; Franco Zunino
Journal:  Biochem Pharmacol       Date:  2014-02-22       Impact factor: 5.858

5.  Proteoglycans regulate autophagy via outside-in signaling: an emerging new concept.

Authors:  Maria A Gubbiotti; Renato V Iozzo
Journal:  Matrix Biol       Date:  2015-10-14       Impact factor: 11.583

6.  Heparanase promotes radiation resistance of cervical cancer by upregulating hypoxia inducible factor 1.

Authors:  Jianping Li; Xin Meng; Jing Hu; Ying Zhang; Yunzhi Dang; Lichun Wei; Mei Shi
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

7.  Transgenic over-expression of mammalian heparanase delays prion disease onset and progression.

Authors:  O Kovalchuk Ben-Zaken; I Nissan; S Tzaban; A Taraboulos; E Zcharia; S Matzger; I Shafat; I Vlodavsky; Y Tal
Journal:  Biochem Biophys Res Commun       Date:  2015-07-10       Impact factor: 3.575

Review 8.  Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression.

Authors:  Israel Vlodavsky; Miriam Gross-Cohen; Marina Weissmann; Neta Ilan; Ralph D Sanderson
Journal:  Trends Biochem Sci       Date:  2017-11-20       Impact factor: 13.807

9.  Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis.

Authors:  Nadine Nagy; Gernot Kaber; Pamela Y Johnson; John A Gebe; Anton Preisinger; Ben A Falk; Vivekananda G Sunkari; Michel D Gooden; Robert B Vernon; Marika Bogdani; Hedwich F Kuipers; Anthony J Day; Daniel J Campbell; Thomas N Wight; Paul L Bollyky
Journal:  J Clin Invest       Date:  2015-09-14       Impact factor: 14.808

10.  Dichotomic role of heparanase in a murine model of metabolic syndrome.

Authors:  Esther Hermano; Françoise Carlotti; Alexia Abecassis; Amichay Meirovitz; Ariel M Rubinstein; Jin-Ping Li; Israel Vlodavsky; Ton J Rabelink; Michael Elkin
Journal:  Cell Mol Life Sci       Date:  2020-10-13       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.